| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Yoav Zvi Waizer last filed a Form 4 in October 2019, as Director at MBOT. Yoav Zvi Waizer's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Yoav Zvi Waizer has 4 Form 4 filings on record from December 2017 to October 2019, all as Director at Microbot Medical (MBOT), 2017–2019.
The 5 reported transactions were 3 option or other derivative awards, 1 open-market purchase and 1 open-market sale.
Counted by filing, the open-market trades come to 1 purchase worth about $11K and 1 sale worth about $11K.
The only open-market purchase was 10,000 shares of MBOT at an average $1.10 on December 4, 2017, about $11K.
The only open-market sale was 10,000 shares of MBOT at an average $1.08 on December 5, 2017, about $11K.
Shares as reported in the last Form 4 for each company; the most recent is from October 2019. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.